Skip to main content

Table 2 Study sample clinical characteristics (n=35)

From: Real-World experience of interictal burden and treatment in migraine: a qualitative interview study

Sample characteristic Statistic
Migraine days per month (last three months) Mean (SD) 12.1 (8.0)
Age at diagnosis Mean (SD) 26.5 (14.0)
Type of migraine N (%)
 Chronic migraine 13 (37%)
 Migraine with aura a 9 (26%)
 Other migraine subtype b 8 (23%)
 Don’t know 9 (26%)
Other long-term conditions
 Anxiety 18 (51%)
 Bipolar disorder 1 (3%)
 Depression 12 (34%)
 Diabetes 2 (6%)
 Fibromyalgia 4 (11%)
 Hypertension 3 (9%)
 Post-traumatic stress disorder 2 (6%)
 Respiratory condition 4 (11%)
 Other 6 (17%)
 None 11 (31%)
Acute Treatments
 Drug Type Current/Most Recent Treatment (All) Past Treatments
 Pain relievers 15 (43%) 14 (40%)
 Triptans 18 (51%) 14 (40%)
 Anti-nausea drugs 1 (3%) 1 (3%)
 Other 4 (11%) 3 (9%)
Preventive Treatments
 Drug Type Current/Most Recent Treatment (All) Past Treatments
 Anti-epileptics 8 (23%) 14 (40%)
 Anti-depressants 2 (6%) 14 (40%)
 Beta-blockers 2 (6%) 13 (37%)
 Neurotoxins (Botox) 4 (11%) 6 (17%)
 Calcium channel blockers 1 (3%)
 Angiotensin receptor blockers 3 (9%)
 CGRP mAbs 7 (20%) a 8 (23%) b
 Other 3 (9%) 1 (3%)
  1. aIncludes classic migraine
  2. bIncludes migraine without aura, intractable migraine (with or without status migrainous), ocular migraine, hemiplegic migraine, vestibular migraine and (hyper) tension migraine